rs121918364
Variant summary
Our verdict is Likely benign. The variant received -6 ACMG points: 0P and 6B. BP4_ModerateBS2
The NM_014467.3(SRPX2):c.215A>C(p.Tyr72Ser) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000413 in 1,209,383 control chromosomes in the GnomAD database, with no homozygous occurrence. There are 13 hemizygotes in GnomAD. In-silico tool predicts a benign outcome for this variant. 13/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).
Frequency
Consequence
NM_014467.3 missense
Scores
Clinical Significance
Conservation
Publications
- rolandic epilepsy-speech dyspraxia syndromeInheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
- polymicrogyria, bilateral perisylvian, X-linkedInheritance: XL Classification: LIMITED Submitted by: G2P
- rolandic epilepsy, intellectual disability, and speech dyspraxia, X-linkedInheritance: XL Classification: LIMITED, NO_KNOWN Submitted by: Ambry Genetics, Labcorp Genetics (formerly Invitae)
Genome browser will be placed here
ACMG classification
Our verdict: Likely_benign. The variant received -6 ACMG points.
Variant Effect in Transcripts
ACMG analysis was done for transcript: NM_014467.3. You can select a different transcript below to see updated ACMG assignments.
RefSeq Transcripts
| Selected | Gene | Transcript | Tags | HGVSc | HGVSp | Effect | Exon Rank | Protein | UniProt |
|---|---|---|---|---|---|---|---|---|---|
| SRPX2 | NM_014467.3 | MANE Select | c.215A>C | p.Tyr72Ser | missense | Exon 4 of 11 | NP_055282.1 |
Ensembl Transcripts
| Selected | Gene | Transcript | Tags | HGVSc | HGVSp | Effect | Exon Rank | Protein | UniProt |
|---|---|---|---|---|---|---|---|---|---|
| SRPX2 | ENST00000373004.5 | TSL:1 MANE Select | c.215A>C | p.Tyr72Ser | missense | Exon 4 of 11 | ENSP00000362095.3 | ||
| SRPX2 | ENST00000638458.1 | TSL:5 | c.239A>C | p.Tyr80Ser | missense | Exon 3 of 7 | ENSP00000492168.1 | ||
| SRPX2 | ENST00000640889.1 | TSL:5 | c.215A>C | p.Tyr72Ser | missense | Exon 4 of 7 | ENSP00000492571.1 |
Frequencies
GnomAD3 genomes AF: 0.0000449 AC: 5AN: 111243Hom.: 0 Cov.: 23 show subpopulations
GnomAD2 exomes AF: 0.0000327 AC: 6AN: 183411 AF XY: 0.0000442 show subpopulations
GnomAD4 exome AF: 0.0000410 AC: 45AN: 1098140Hom.: 0 Cov.: 31 AF XY: 0.0000330 AC XY: 12AN XY: 363494 show subpopulations
Age Distribution
GnomAD4 genome AF: 0.0000449 AC: 5AN: 111243Hom.: 0 Cov.: 23 AF XY: 0.0000298 AC XY: 1AN XY: 33519 show subpopulations
Age Distribution
ClinVar
Submissions by phenotype
Rolandic epilepsy, intellectual disability, and speech dyspraxia, X-linked Pathogenic:1Uncertain:1
This variant has been reported to affect SRPX2 protein function (PMID: 16497722, 23831613, 18718938). In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. This variant has been observed in individual(s) with SRPX2-related conditions (PMID: 16497722). ClinVar contains an entry for this variant (Variation ID: 10776). This sequence change replaces tyrosine with serine at codon 72 of the SRPX2 protein (p.Tyr72Ser). The tyrosine residue is highly conserved and there is a large physicochemical difference between tyrosine and serine. This variant is present in population databases (rs121918364, ExAC 0.002%).
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at